Related Experiment Videos
Simultaneous Resection for Synchronous Colorectal Liver Metastasis: the New Standard of Care?
Jonathan S Abelson1, Fabrizio Michelassi1, Tianyi Sun2
1Department of Surgery, New York Presbyterian Hospital - Weill Cornell Medical Center, 525 East 68th Street, New York, NY, 10065, USA.
Summary
Simultaneous resection for synchronous colorectal cancer liver metastasis is as safe as staged surgery. This approach reduces hospital stay and costs, making it a recommended option for patients.
Area of Science:
- Surgical Oncology
- Gastroenterology
- Hepatobiliary Surgery
Background:
- Optimal surgical management for synchronous colorectal cancer liver metastasis remains debated.
- This study analyzes surgical utilization and outcomes for simultaneous versus staged resection approaches.
Purpose of the Study:
- To compare the safety and outcomes of simultaneous versus staged surgical resection for synchronous colorectal cancer liver metastasis.
- To evaluate health care utilization associated with each approach.
Main Methods:
- Retrospective analysis of 1430 patients from the SPARCS database (2005-2014).
- Identification of staged and simultaneous resections using ICD-9 codes.
- Primary endpoint: 30-day major adverse events.
Main Results:
- No significant difference in major adverse events or anastomotic leak rates between simultaneous and staged resection.
- Simultaneous resection was associated with significantly shorter length of stay and lower hospital charges.
- These benefits persisted even in complex cases involving hepatic lobectomy or extensive colorectal resection.
Conclusions:
- Simultaneous resection is as safe as staged resection for synchronous colorectal cancer liver metastasis.
- Simultaneous resection leads to lower healthcare utilization.
- Simultaneous resection should be the recommended surgical approach when clinically appropriate.